These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9550601)

  • 1. Fas-induced apoptosis.
    Nagata S
    Intern Med; 1998 Feb; 37(2):179-81. PubMed ID: 9550601
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell death induced by the Fas/Fas ligand pathway and its role in pathology.
    Waring P; Müllbacher A
    Immunol Cell Biol; 1999 Aug; 77(4):312-7. PubMed ID: 10457197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mature but not immature Fas ligand (CD95L)-transduced human monocyte-derived dendritic cells are protected from Fas-mediated apoptosis and can be used as killer APC.
    Hoves S; Krause SW; Halbritter D; Zhang HG; Mountz JD; Schölmerich J; Fleck M
    J Immunol; 2003 Jun; 170(11):5406-13. PubMed ID: 12759415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-Myb overexpression results in activation and increased Fas/Fas ligand-mediated cytotoxicity of T and NK cells.
    Powzaniuk MA; Trotta R; Loza MJ; Harth A; Iozzo RV; Eisenlohr LC; Perussia B; Calabretta B
    J Immunol; 2001 Jul; 167(1):242-9. PubMed ID: 11418655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of Jurkat T-cell apoptosis by Fas ligand-transfected endothelial cells.
    Cappellesso S; Thibault G; Hoarau C; Watier H; Bardos P; Lebranchu Y
    Transplant Proc; 2000 Dec; 32(8):2737-8. PubMed ID: 11134778
    [No Abstract]   [Full Text] [Related]  

  • 6. Zeta-associated protein of 70 kDa (ZAP-70), but not Syk, tyrosine kinase can mediate apoptosis of T cells through the Fas/Fas ligand, caspase-8 and caspase-3 pathways.
    Zhong L; Wu CH; Lee WH; Liu CP
    J Immunol; 2004 Feb; 172(3):1472-82. PubMed ID: 14734724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble Fas modulates interferon responsiveness.
    Tsai SL
    J Gastroenterol Hepatol; 2001 Sep; 16(9):958-9. PubMed ID: 11595057
    [No Abstract]   [Full Text] [Related]  

  • 8. Fas and the immunologically underprivileged intestine.
    Ma A
    Gastroenterology; 1997 Jul; 113(1):345-8. PubMed ID: 9207297
    [No Abstract]   [Full Text] [Related]  

  • 9. Fibronectin-associated Fas ligand rapidly induces opposing and time-dependent effects on the activation and apoptosis of T cells.
    Zanin-Zhorov A; Hershkoviz R; Hecht I; Cahalon L; Lider O
    J Immunol; 2003 Dec; 171(11):5882-9. PubMed ID: 14634098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fas ligand--caught between Scylla and Charybdis.
    Strasser A; O'Connor L
    Nat Med; 1998 Jan; 4(1):21-2. PubMed ID: 9427600
    [No Abstract]   [Full Text] [Related]  

  • 11. Rosmarinic acid induces p56lck-dependent apoptosis in Jurkat and peripheral T cells via mitochondrial pathway independent from Fas/Fas ligand interaction.
    Hur YG; Yun Y; Won J
    J Immunol; 2004 Jan; 172(1):79-87. PubMed ID: 14688312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Fas-based mechanism of lymphocytotoxicity.
    Berke G
    Hum Immunol; 1997 Apr; 54(1):1-7. PubMed ID: 9154451
    [No Abstract]   [Full Text] [Related]  

  • 13. The Fas counterattack: cancer as a site of immune privilege.
    O'Connell J; Bennett MW; O'Sullivan GC; Collins JK; Shanahan F
    Immunol Today; 1999 Jan; 20(1):46-52. PubMed ID: 10081230
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumor cells fight back to beat immune system.
    Williams N
    Science; 1996 Nov; 274(5291):1302. PubMed ID: 8966600
    [No Abstract]   [Full Text] [Related]  

  • 15. Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis.
    Kuwano K; Hagimoto N; Kawasaki M; Yatomi T; Nakamura N; Nagata S; Suda T; Kunitake R; Maeyama T; Miyazaki H; Hara N
    J Clin Invest; 1999 Jul; 104(1):13-9. PubMed ID: 10393694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the Fas ligand/Fas-dependent apoptosis of antiretroviral, class I MHC tetramer-defined, CD8+ CTL by in vivo retrovirus-infected cells.
    Rich RF; Green WR
    J Immunol; 2002 Mar; 168(6):2751-8. PubMed ID: 11884442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fas-mediated apoptosis causes elimination of virus-specific cytotoxic T cells in the virus-infected liver.
    Liu ZX; Govindarajan S; Okamoto S; Dennert G
    J Immunol; 2001 Mar; 166(5):3035-41. PubMed ID: 11207253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. II. Deletion of effector cells by Fas-Fas ligand apoptosis.
    Reich-Zeliger S; Gan J; Bachar-Lustig E; Reisner Y
    J Immunol; 2004 Dec; 173(11):6660-6. PubMed ID: 15557157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes.
    Apolloni E; Bronte V; Mazzoni A; Serafini P; Cabrelle A; Segal DM; Young HA; Zanovello P
    J Immunol; 2000 Dec; 165(12):6723-30. PubMed ID: 11120790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fas ligand and immune evasion.
    Nagata S
    Nat Med; 1996 Dec; 2(12):1306-7. PubMed ID: 8946823
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.